Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Rosseti Siberia reported for 6 months of 2023 by RAS

7/28/23 MRKS

Ozon listed on the Astana International Exchange

7/28/23 OZON

Yandex plans to present restructuring plans to shareholders by the end of the year

7/28/23 YNDX

The Intel announced a quarterly dividend

7/28/23 INTC

Lenta reported for 6 months of 2023 by IFRS

7/28/23 LENT

Lenta reported a decline in all operating indicators in the first half of the year

7/28/23 LENT

L3Harris bought Aerojet Rocketdyne

7/28/23 LHX

L3Harris bought Aerojet Rocketdyne

7/28/23 AJRD

Ford has reported for 6 months of 2023

7/28/23 F

First Solar reported for 6 months of 2023

7/28/23 FSLR